Trial intelligence / Profile preview

SOR007 Ointment for Actinic Keratosis

NCT03083470Phase 2Completed

Sponsor
DFB Soria
Start
May 2017
Primary completion
Mar 2018
Countries
1
01

Overview

A Phase 2 trial of SOR007 Ointment Placebo in actinic keratosis (AK), sponsored by DFB Soria. Started May 2017; status: completed.

02

Drugs

SOR007 Ointment Placebo
03

Conditions

actinic keratosis (AK)

Beyond the preview

Go deeper on NCT03083470.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03083470.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call